Dosing has begun in a Phase 2 clinical trial testing the experimental oral therapy SAT-3247 in boys with Duchenne muscular ...

Guest writer Matthew Busch says that, despite the setbacks and surgeries he's endured, he's now thriving in life with Duchenne MD.

A clinical trial testing Duchenne gene-editing therapy candidate PBGENE-DMD will soon launch in the U.S., having won ...

A Phase 3 clinical trial testing SGT-003, a gene therapy candidate for Duchenne muscular dystrophy (DMD), will start dosing ...

An honest answer about her sons would mean talking about all the things Duchenne MD has taken from them, writes columnist.

When faced with a bad moment or adverse event, columnist Patrick Moeschen says it helps to remember the rule of 10.

Dangerous snow and ice, along with FSHD symptoms, made it impossible for columnist Robin Stemple to leave his home for two weeks.

Columnist Betty Vertin is grateful she's been able to manage cold and flu season at home for her three sons with DMD, and her whole family.

The FDA has granted fast track designation to Dyscorban, Cumberland's therapy candidate for heart problems in people with Duchenne MD.

Columnist Shalom Lim experienced a range of emotions while watching other actors perform a play he wrote about muscular dystrophy.

Aging with muscular dystrophy (MD) can involve gradual changes in strength, mobility, and daily functioning. Understanding MD progression can help you and your family anticipate these changes and plan ...